Recent coverage
Front-page news, podcasts and videos about Dina
Tasso, Inc. obtains Health Canada license and EU approvals to sell Tasso Mini in Canada, Italy, and Spain
Tasso, Inc. received Health Canada licensing and additional EU approvals allowing its Tasso Mini blood collection device to be sold in Canada, Italy, and Spain, expanding availability beyond its existing U.S. FDA 510(k) clearance and CE Marking. The Tasso Mini is designed for gentle, virtually painless sampling for sensitive or repeat-use patients and now matches the international availability of Tasso’s flagship Tasso+® device.
Tasso, Inc. renews SOC 2 Type II certification with unqualified opinion after Prescient Assurance audit
Tasso, Inc. renewed its SOC 2 Type II compliance certification with an unqualified (clean) opinion after an independent audit by Prescient Assurance, affirming its enterprise-level data security across platforms and APIs. The renewal underscores Tasso’s commitment to protecting sensitive patient data for its patient-centric blood collection solutions.
By Dina
Tasso Launches Tasso Care® for Prescreening to Streamline At‑Home Clinical Trial Screening
Tasso launched Tasso Care® for Prescreening, a full-service, at-home blood collection and analysis platform that streamlines clinical trial prescreening to boost enrollment, diversity, and sample quality while expanding panels for multiple therapeutic areas.
Tasso announces CE Mark for Tasso+™ lancet, achieving EU market access and joining prior U.S. 510(k) clearance
Tasso announced CE Mark certification for its Tasso+™ virtually pain-free whole blood collection lancet, enabling sales across the EU and marking full clearance after prior FDA 510(k) Class II clearance; the device aims to expand decentralized clinical trials, home diagnostics, and remote testing access in Europe.
Organizations
-
Tasso Media Contact · current
